Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has spread worldwide through person-to-person contact, causing a public health emergency of international concern. At present, there is no specific antiviral treatment recommended for SARS-CoV-2 infection. Liu Shen capsule (LS), a traditio...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Pharmacol Res
Päätekijät: Ma, Qinhai, Pan, Weiqi, Li, Runfeng, Liu, Bin, Li, Chufang, Xie, Yuqi, Wang, Zhoulang, Zhao, Jin, Jiang, Haiming, Huang, Jicheng, Shi, Yongxia, Dai, Jun, Zheng, Kui, Li, Xiaobo, Yang, Zifeng
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier Ltd. 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7192119/
https://ncbi.nlm.nih.gov/pubmed/32360580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phrs.2020.104850
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia